Literature DB >> 8028622

The continuing unethical use of placebo controls.

K J Rothman1, K B Michels.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8028622     DOI: 10.1056/NEJM199408113310611

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  94 in total

1.  Ethical issues in schizophrenia research.

Authors:  R B Zipursky
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Placebos and placebo effects in medicine: historical overview.

Authors:  A J de Craen; T J Kaptchuk; J G Tijssen; J Kleijnen
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

3.  Placebo-controlled trials: good science or medical neglect?

Authors:  G T Chiodo; S W Tolle; L Bevan
Journal:  West J Med       Date:  2000-04

4.  Declaration of Helsinki should be strengthened.

Authors:  K J Rothman
Journal:  BMJ       Date:  2000-08-12

5.  The better-than-nothing idea: debating the use of placebo controls.

Authors: 
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

6.  Acknowledgment of uncertainty: a fundamental means to ensure scientific and ethical validity in clinical research.

Authors:  B Djulbegovic
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

Review 7.  Design of clinical trials of antidepressants: should a placebo control arm be included?

Authors:  J Fritze; H J Möller
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 8.  Benefits and burdens of placebos in psychiatric research.

Authors:  Scott Y H Kim
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

Review 9.  Evaluation of new therapies for inflammatory bowel disease.

Authors:  E Carty; D S Rampton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

10.  The revision of the Declaration of Helsinki: past, present and future.

Authors:  Robert V Carlson; Kenneth M Boyd; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.